Novatti Group Limited
Get $10 bonus on your first $100 deposit for NOV.AX
Get $10 bonus on your first $100 deposit for NOV.AX
Novatti Group Limited (NOV.AX) Stock Competitors & Peer Comparison
See (NOV.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Infrastructure Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NOV.AX | A$0.03 | +4.00% | 15.5M | -1.25 | -A$0.02 | N/A |
| SQ2.AX | A$140.94 | +0.00% | 88.3B | 52.98 | A$2.66 | N/A |
| XYZ.AX | A$93.00 | +7.23% | 56.7B | 30.71 | A$2.98 | N/A |
| PPH.AX | A$1.32 | +0.00% | 1.5B | 44.00 | A$0.03 | N/A |
| MP1.AX | A$7.57 | +10.35% | 1.3B | -55.15 | -A$0.13 | N/A |
| GTK.AX | A$5.04 | -2.51% | 579.1M | 32.19 | A$0.16 | N/A |
| TYR.AX | A$0.77 | +0.65% | 403.6M | 15.20 | A$0.05 | N/A |
| QOR.AX | A$0.30 | +9.09% | 391.7M | -7.12 | -A$0.04 | N/A |
| SMP.AX | A$1.05 | +0.00% | 252.8M | 34.83 | A$0.03 | N/A |
| ACE.AX | A$1.60 | +6.67% | 216.3M | -9.00 | -A$0.17 | N/A |
Stock Comparison
NOV.AX vs SQ2.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, SQ2.AX has a market cap of 88.3B. Regarding current trading prices, NOV.AX is priced at A$0.03, while SQ2.AX trades at A$140.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas SQ2.AX's P/E ratio is 52.98. In terms of profitability, NOV.AX's ROE is -0.78%, compared to SQ2.AX's ROE of +0.14%. Regarding short-term risk, NOV.AX is more volatile compared to SQ2.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check SQ2.AX's competition here
NOV.AX vs XYZ.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, XYZ.AX has a market cap of 56.7B. Regarding current trading prices, NOV.AX is priced at A$0.03, while XYZ.AX trades at A$93.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas XYZ.AX's P/E ratio is 30.71. In terms of profitability, NOV.AX's ROE is -0.78%, compared to XYZ.AX's ROE of +0.06%. Regarding short-term risk, NOV.AX is more volatile compared to XYZ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check XYZ.AX's competition here
NOV.AX vs PPH.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, PPH.AX has a market cap of 1.5B. Regarding current trading prices, NOV.AX is priced at A$0.03, while PPH.AX trades at A$1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas PPH.AX's P/E ratio is 44.00. In terms of profitability, NOV.AX's ROE is -0.78%, compared to PPH.AX's ROE of +0.26%. Regarding short-term risk, NOV.AX is more volatile compared to PPH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check PPH.AX's competition here
NOV.AX vs MP1.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, MP1.AX has a market cap of 1.3B. Regarding current trading prices, NOV.AX is priced at A$0.03, while MP1.AX trades at A$7.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas MP1.AX's P/E ratio is -55.15. In terms of profitability, NOV.AX's ROE is -0.78%, compared to MP1.AX's ROE of -0.06%. Regarding short-term risk, NOV.AX is less volatile compared to MP1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check MP1.AX's competition here
NOV.AX vs GTK.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, GTK.AX has a market cap of 579.1M. Regarding current trading prices, NOV.AX is priced at A$0.03, while GTK.AX trades at A$5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas GTK.AX's P/E ratio is 32.19. In terms of profitability, NOV.AX's ROE is -0.78%, compared to GTK.AX's ROE of +0.09%. Regarding short-term risk, NOV.AX is more volatile compared to GTK.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check GTK.AX's competition here
NOV.AX vs TYR.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, TYR.AX has a market cap of 403.6M. Regarding current trading prices, NOV.AX is priced at A$0.03, while TYR.AX trades at A$0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas TYR.AX's P/E ratio is 15.20. In terms of profitability, NOV.AX's ROE is -0.78%, compared to TYR.AX's ROE of +0.11%. Regarding short-term risk, NOV.AX is more volatile compared to TYR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check TYR.AX's competition here
NOV.AX vs QOR.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, QOR.AX has a market cap of 391.7M. Regarding current trading prices, NOV.AX is priced at A$0.03, while QOR.AX trades at A$0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas QOR.AX's P/E ratio is -7.12. In terms of profitability, NOV.AX's ROE is -0.78%, compared to QOR.AX's ROE of -0.32%. Regarding short-term risk, NOV.AX is less volatile compared to QOR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check QOR.AX's competition here
NOV.AX vs SMP.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, SMP.AX has a market cap of 252.8M. Regarding current trading prices, NOV.AX is priced at A$0.03, while SMP.AX trades at A$1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas SMP.AX's P/E ratio is 34.83. In terms of profitability, NOV.AX's ROE is -0.78%, compared to SMP.AX's ROE of -0.01%. Regarding short-term risk, NOV.AX is more volatile compared to SMP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check SMP.AX's competition here
NOV.AX vs ACE.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, ACE.AX has a market cap of 216.3M. Regarding current trading prices, NOV.AX is priced at A$0.03, while ACE.AX trades at A$1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas ACE.AX's P/E ratio is -9.00. In terms of profitability, NOV.AX's ROE is -0.78%, compared to ACE.AX's ROE of -0.45%. Regarding short-term risk, NOV.AX is less volatile compared to ACE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check ACE.AX's competition here
NOV.AX vs WRK.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, WRK.AX has a market cap of 209.5M. Regarding current trading prices, NOV.AX is priced at A$0.03, while WRK.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas WRK.AX's P/E ratio is N/A. In terms of profitability, NOV.AX's ROE is -0.78%, compared to WRK.AX's ROE of -0.16%. Regarding short-term risk, NOV.AX is less volatile compared to WRK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check WRK.AX's competition here
NOV.AX vs SKO.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, SKO.AX has a market cap of 190.6M. Regarding current trading prices, NOV.AX is priced at A$0.03, while SKO.AX trades at A$1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas SKO.AX's P/E ratio is -8.50. In terms of profitability, NOV.AX's ROE is -0.78%, compared to SKO.AX's ROE of -0.27%. Regarding short-term risk, NOV.AX is more volatile compared to SKO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check SKO.AX's competition here
NOV.AX vs A2B.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, A2B.AX has a market cap of 181.3M. Regarding current trading prices, NOV.AX is priced at A$0.03, while A2B.AX trades at A$1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas A2B.AX's P/E ratio is 2.41. In terms of profitability, NOV.AX's ROE is -0.78%, compared to A2B.AX's ROE of +0.27%. Regarding short-term risk, NOV.AX is more volatile compared to A2B.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check A2B.AX's competition here
NOV.AX vs DAI.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, DAI.AX has a market cap of 178.6M. Regarding current trading prices, NOV.AX is priced at A$0.03, while DAI.AX trades at A$0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas DAI.AX's P/E ratio is -3.47. In terms of profitability, NOV.AX's ROE is -0.78%, compared to DAI.AX's ROE of -7.25%. Regarding short-term risk, NOV.AX is less volatile compared to DAI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check DAI.AX's competition here
NOV.AX vs TNT.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, TNT.AX has a market cap of 172M. Regarding current trading prices, NOV.AX is priced at A$0.03, while TNT.AX trades at A$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas TNT.AX's P/E ratio is -12.70. In terms of profitability, NOV.AX's ROE is -0.78%, compared to TNT.AX's ROE of -0.04%. Regarding short-term risk, NOV.AX and TNT.AX have similar daily volatility (3.92).Check TNT.AX's competition here
NOV.AX vs FZO.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, FZO.AX has a market cap of 169M. Regarding current trading prices, NOV.AX is priced at A$0.03, while FZO.AX trades at A$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas FZO.AX's P/E ratio is -1.78. In terms of profitability, NOV.AX's ROE is -0.78%, compared to FZO.AX's ROE of -0.64%. Regarding short-term risk, NOV.AX is more volatile compared to FZO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check FZO.AX's competition here
NOV.AX vs ERD.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, ERD.AX has a market cap of 144.4M. Regarding current trading prices, NOV.AX is priced at A$0.03, while ERD.AX trades at A$0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas ERD.AX's P/E ratio is -1.24. In terms of profitability, NOV.AX's ROE is -0.78%, compared to ERD.AX's ROE of -0.54%. Regarding short-term risk, NOV.AX is less volatile compared to ERD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check ERD.AX's competition here
NOV.AX vs EPX.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, EPX.AX has a market cap of 135.1M. Regarding current trading prices, NOV.AX is priced at A$0.03, while EPX.AX trades at A$0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas EPX.AX's P/E ratio is -2.10. In terms of profitability, NOV.AX's ROE is -0.78%, compared to EPX.AX's ROE of -4.56%. Regarding short-term risk, NOV.AX is less volatile compared to EPX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check EPX.AX's competition here
NOV.AX vs AV1.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, AV1.AX has a market cap of 89M. Regarding current trading prices, NOV.AX is priced at A$0.03, while AV1.AX trades at A$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas AV1.AX's P/E ratio is -9.60. In terms of profitability, NOV.AX's ROE is -0.78%, compared to AV1.AX's ROE of -1.62%. Regarding short-term risk, NOV.AX is less volatile compared to AV1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check AV1.AX's competition here
NOV.AX vs B4P.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, B4P.AX has a market cap of 75.9M. Regarding current trading prices, NOV.AX is priced at A$0.03, while B4P.AX trades at A$1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas B4P.AX's P/E ratio is 9.53. In terms of profitability, NOV.AX's ROE is -0.78%, compared to B4P.AX's ROE of +0.19%. Regarding short-term risk, NOV.AX is less volatile compared to B4P.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check B4P.AX's competition here
NOV.AX vs CC5.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, CC5.AX has a market cap of 58.8M. Regarding current trading prices, NOV.AX is priced at A$0.03, while CC5.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas CC5.AX's P/E ratio is N/A. In terms of profitability, NOV.AX's ROE is -0.78%, compared to CC5.AX's ROE of +0.42%. Regarding short-term risk, NOV.AX is less volatile compared to CC5.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check CC5.AX's competition here
NOV.AX vs FND.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, FND.AX has a market cap of 49.3M. Regarding current trading prices, NOV.AX is priced at A$0.03, while FND.AX trades at A$0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas FND.AX's P/E ratio is -1.45. In terms of profitability, NOV.AX's ROE is -0.78%, compared to FND.AX's ROE of -0.58%. Regarding short-term risk, NOV.AX is less volatile compared to FND.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check FND.AX's competition here
NOV.AX vs OPY.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, OPY.AX has a market cap of 45.4M. Regarding current trading prices, NOV.AX is priced at A$0.03, while OPY.AX trades at A$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas OPY.AX's P/E ratio is -0.31. In terms of profitability, NOV.AX's ROE is -0.78%, compared to OPY.AX's ROE of -4.51%. Regarding short-term risk, NOV.AX is more volatile compared to OPY.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check OPY.AX's competition here
NOV.AX vs DCC.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, DCC.AX has a market cap of 44.7M. Regarding current trading prices, NOV.AX is priced at A$0.03, while DCC.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas DCC.AX's P/E ratio is -3.00. In terms of profitability, NOV.AX's ROE is -0.78%, compared to DCC.AX's ROE of -0.07%. Regarding short-term risk, NOV.AX is more volatile compared to DCC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check DCC.AX's competition here
NOV.AX vs IOU.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, IOU.AX has a market cap of 43.8M. Regarding current trading prices, NOV.AX is priced at A$0.03, while IOU.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas IOU.AX's P/E ratio is -4.10. In terms of profitability, NOV.AX's ROE is -0.78%, compared to IOU.AX's ROE of -1.21%. Regarding short-term risk, NOV.AX is less volatile compared to IOU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check IOU.AX's competition here
NOV.AX vs SOV.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, SOV.AX has a market cap of 42.5M. Regarding current trading prices, NOV.AX is priced at A$0.03, while SOV.AX trades at A$0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas SOV.AX's P/E ratio is -2.17. In terms of profitability, NOV.AX's ROE is -0.78%, compared to SOV.AX's ROE of -0.58%. Regarding short-term risk, NOV.AX is more volatile compared to SOV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check SOV.AX's competition here
NOV.AX vs SEN.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, SEN.AX has a market cap of 36.1M. Regarding current trading prices, NOV.AX is priced at A$0.03, while SEN.AX trades at A$2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas SEN.AX's P/E ratio is -2.20. In terms of profitability, NOV.AX's ROE is -0.78%, compared to SEN.AX's ROE of -0.65%. Regarding short-term risk, NOV.AX is more volatile compared to SEN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check SEN.AX's competition here
NOV.AX vs RTH.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, RTH.AX has a market cap of 35.2M. Regarding current trading prices, NOV.AX is priced at A$0.03, while RTH.AX trades at A$0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas RTH.AX's P/E ratio is -73.50. In terms of profitability, NOV.AX's ROE is -0.78%, compared to RTH.AX's ROE of -0.02%. Regarding short-term risk, NOV.AX is more volatile compared to RTH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check RTH.AX's competition here
NOV.AX vs QFE.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, QFE.AX has a market cap of 29.9M. Regarding current trading prices, NOV.AX is priced at A$0.03, while QFE.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas QFE.AX's P/E ratio is 0.87. In terms of profitability, NOV.AX's ROE is -0.78%, compared to QFE.AX's ROE of +3.50%. Regarding short-term risk, NOV.AX is more volatile compared to QFE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check QFE.AX's competition here
NOV.AX vs SPT.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, SPT.AX has a market cap of 27.8M. Regarding current trading prices, NOV.AX is priced at A$0.03, while SPT.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas SPT.AX's P/E ratio is -1.07. In terms of profitability, NOV.AX's ROE is -0.78%, compared to SPT.AX's ROE of -0.69%. Regarding short-term risk, NOV.AX is less volatile compared to SPT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check SPT.AX's competition here
NOV.AX vs EAT.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, EAT.AX has a market cap of 26.9M. Regarding current trading prices, NOV.AX is priced at A$0.03, while EAT.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas EAT.AX's P/E ratio is -2.10. In terms of profitability, NOV.AX's ROE is -0.78%, compared to EAT.AX's ROE of +0.68%. Regarding short-term risk, NOV.AX is more volatile compared to EAT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check EAT.AX's competition here
NOV.AX vs HSC.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, HSC.AX has a market cap of 25.1M. Regarding current trading prices, NOV.AX is priced at A$0.03, while HSC.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas HSC.AX's P/E ratio is N/A. In terms of profitability, NOV.AX's ROE is -0.78%, compared to HSC.AX's ROE of -0.53%. Regarding short-term risk, NOV.AX is less volatile compared to HSC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check HSC.AX's competition here
NOV.AX vs BUD.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, BUD.AX has a market cap of 21.1M. Regarding current trading prices, NOV.AX is priced at A$0.03, while BUD.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas BUD.AX's P/E ratio is -0.30. In terms of profitability, NOV.AX's ROE is -0.78%, compared to BUD.AX's ROE of -0.23%. Regarding short-term risk, NOV.AX is more volatile compared to BUD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check BUD.AX's competition here
NOV.AX vs TAL.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, TAL.AX has a market cap of 18.7M. Regarding current trading prices, NOV.AX is priced at A$0.03, while TAL.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas TAL.AX's P/E ratio is -5.50. In terms of profitability, NOV.AX's ROE is -0.78%, compared to TAL.AX's ROE of -0.53%. Regarding short-term risk, NOV.AX is less volatile compared to TAL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check TAL.AX's competition here
NOV.AX vs IXU.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, IXU.AX has a market cap of 18.3M. Regarding current trading prices, NOV.AX is priced at A$0.03, while IXU.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas IXU.AX's P/E ratio is -0.90. In terms of profitability, NOV.AX's ROE is -0.78%, compared to IXU.AX's ROE of -4.33%. Regarding short-term risk, NOV.AX is more volatile compared to IXU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check IXU.AX's competition here
NOV.AX vs W2V.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, W2V.AX has a market cap of 17.1M. Regarding current trading prices, NOV.AX is priced at A$0.03, while W2V.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas W2V.AX's P/E ratio is -1.92. In terms of profitability, NOV.AX's ROE is -0.78%, compared to W2V.AX's ROE of -5.84%. Regarding short-term risk, NOV.AX is less volatile compared to W2V.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check W2V.AX's competition here
NOV.AX vs DWG.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, DWG.AX has a market cap of 16.5M. Regarding current trading prices, NOV.AX is priced at A$0.03, while DWG.AX trades at A$0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas DWG.AX's P/E ratio is -2.29. In terms of profitability, NOV.AX's ROE is -0.78%, compared to DWG.AX's ROE of -4.33%. Regarding short-term risk, NOV.AX is more volatile compared to DWG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check DWG.AX's competition here
NOV.AX vs RXH.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, RXH.AX has a market cap of 15.3M. Regarding current trading prices, NOV.AX is priced at A$0.03, while RXH.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas RXH.AX's P/E ratio is 2.90. In terms of profitability, NOV.AX's ROE is -0.78%, compared to RXH.AX's ROE of +0.93%. Regarding short-term risk, NOV.AX is more volatile compared to RXH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check RXH.AX's competition here
NOV.AX vs EXT.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, EXT.AX has a market cap of 14.6M. Regarding current trading prices, NOV.AX is priced at A$0.03, while EXT.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas EXT.AX's P/E ratio is N/A. In terms of profitability, NOV.AX's ROE is -0.78%, compared to EXT.AX's ROE of +9.09%. Regarding short-term risk, NOV.AX is less volatile compared to EXT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check EXT.AX's competition here
NOV.AX vs SKF.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, SKF.AX has a market cap of 13M. Regarding current trading prices, NOV.AX is priced at A$0.03, while SKF.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas SKF.AX's P/E ratio is -1.55. In terms of profitability, NOV.AX's ROE is -0.78%, compared to SKF.AX's ROE of -0.97%. Regarding short-term risk, NOV.AX is less volatile compared to SKF.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check SKF.AX's competition here
NOV.AX vs CYB.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, CYB.AX has a market cap of 11.9M. Regarding current trading prices, NOV.AX is priced at A$0.03, while CYB.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas CYB.AX's P/E ratio is -0.47. In terms of profitability, NOV.AX's ROE is -0.78%, compared to CYB.AX's ROE of -1.48%. Regarding short-term risk, NOV.AX is more volatile compared to CYB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check CYB.AX's competition here
NOV.AX vs PIL.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, PIL.AX has a market cap of 11.7M. Regarding current trading prices, NOV.AX is priced at A$0.03, while PIL.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas PIL.AX's P/E ratio is N/A. In terms of profitability, NOV.AX's ROE is -0.78%, compared to PIL.AX's ROE of +2.57%. Regarding short-term risk, NOV.AX is more volatile compared to PIL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check PIL.AX's competition here
NOV.AX vs BEO.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, BEO.AX has a market cap of 7.5M. Regarding current trading prices, NOV.AX is priced at A$0.03, while BEO.AX trades at A$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas BEO.AX's P/E ratio is -3.67. In terms of profitability, NOV.AX's ROE is -0.78%, compared to BEO.AX's ROE of -4.30%. Regarding short-term risk, NOV.AX is less volatile compared to BEO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check BEO.AX's competition here
NOV.AX vs S3N.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, S3N.AX has a market cap of 6.8M. Regarding current trading prices, NOV.AX is priced at A$0.03, while S3N.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas S3N.AX's P/E ratio is -0.33. In terms of profitability, NOV.AX's ROE is -0.78%, compared to S3N.AX's ROE of -0.39%. Regarding short-term risk, NOV.AX is more volatile compared to S3N.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check S3N.AX's competition here
NOV.AX vs INP.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, INP.AX has a market cap of 6.5M. Regarding current trading prices, NOV.AX is priced at A$0.03, while INP.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas INP.AX's P/E ratio is -0.50. In terms of profitability, NOV.AX's ROE is -0.78%, compared to INP.AX's ROE of +0.30%. Regarding short-term risk, NOV.AX is more volatile compared to INP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check INP.AX's competition here
NOV.AX vs WHK.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, WHK.AX has a market cap of 6.4M. Regarding current trading prices, NOV.AX is priced at A$0.03, while WHK.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas WHK.AX's P/E ratio is -0.70. In terms of profitability, NOV.AX's ROE is -0.78%, compared to WHK.AX's ROE of -6.59%. Regarding short-term risk, NOV.AX is less volatile compared to WHK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check WHK.AX's competition here
NOV.AX vs FCT.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, FCT.AX has a market cap of 6.4M. Regarding current trading prices, NOV.AX is priced at A$0.03, while FCT.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas FCT.AX's P/E ratio is -0.40. In terms of profitability, NOV.AX's ROE is -0.78%, compared to FCT.AX's ROE of -0.16%. Regarding short-term risk, NOV.AX is less volatile compared to FCT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check FCT.AX's competition here
NOV.AX vs XPN.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, XPN.AX has a market cap of 6.2M. Regarding current trading prices, NOV.AX is priced at A$0.03, while XPN.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas XPN.AX's P/E ratio is -0.80. In terms of profitability, NOV.AX's ROE is -0.78%, compared to XPN.AX's ROE of +0.22%. Regarding short-term risk, NOV.AX is less volatile compared to XPN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check XPN.AX's competition here
NOV.AX vs GTH.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, GTH.AX has a market cap of 6.1M. Regarding current trading prices, NOV.AX is priced at A$0.03, while GTH.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas GTH.AX's P/E ratio is N/A. In terms of profitability, NOV.AX's ROE is -0.78%, compared to GTH.AX's ROE of -0.65%. Regarding short-term risk, NOV.AX is less volatile compared to GTH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check GTH.AX's competition here
NOV.AX vs RCW.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, RCW.AX has a market cap of 6.1M. Regarding current trading prices, NOV.AX is priced at A$0.03, while RCW.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas RCW.AX's P/E ratio is -2.30. In terms of profitability, NOV.AX's ROE is -0.78%, compared to RCW.AX's ROE of -1.35%. Regarding short-term risk, NOV.AX is less volatile compared to RCW.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check RCW.AX's competition here
NOV.AX vs ADS.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, ADS.AX has a market cap of 5.9M. Regarding current trading prices, NOV.AX is priced at A$0.03, while ADS.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas ADS.AX's P/E ratio is -0.10. In terms of profitability, NOV.AX's ROE is -0.78%, compared to ADS.AX's ROE of +0.53%. Regarding short-term risk, NOV.AX is more volatile compared to ADS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check ADS.AX's competition here
NOV.AX vs CPT.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, CPT.AX has a market cap of 5.8M. Regarding current trading prices, NOV.AX is priced at A$0.03, while CPT.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas CPT.AX's P/E ratio is -0.50. In terms of profitability, NOV.AX's ROE is -0.78%, compared to CPT.AX's ROE of -4.85%. Regarding short-term risk, NOV.AX is less volatile compared to CPT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check CPT.AX's competition here
NOV.AX vs KNO.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, KNO.AX has a market cap of 4.8M. Regarding current trading prices, NOV.AX is priced at A$0.03, while KNO.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas KNO.AX's P/E ratio is -2.20. In terms of profitability, NOV.AX's ROE is -0.78%, compared to KNO.AX's ROE of -0.53%. Regarding short-term risk, NOV.AX is more volatile compared to KNO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check KNO.AX's competition here
NOV.AX vs NNG.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, NNG.AX has a market cap of 4M. Regarding current trading prices, NOV.AX is priced at A$0.03, while NNG.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas NNG.AX's P/E ratio is -2.00. In terms of profitability, NOV.AX's ROE is -0.78%, compared to NNG.AX's ROE of +0.20%. Regarding short-term risk, NOV.AX is less volatile compared to NNG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check NNG.AX's competition here
NOV.AX vs FTC.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, FTC.AX has a market cap of 2.6M. Regarding current trading prices, NOV.AX is priced at A$0.03, while FTC.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas FTC.AX's P/E ratio is -0.40. In terms of profitability, NOV.AX's ROE is -0.78%, compared to FTC.AX's ROE of +0.72%. Regarding short-term risk, NOV.AX is more volatile compared to FTC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for NOV.AX.Check FTC.AX's competition here
NOV.AX vs SPX.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, SPX.AX has a market cap of 973K. Regarding current trading prices, NOV.AX is priced at A$0.03, while SPX.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas SPX.AX's P/E ratio is -0.20. In terms of profitability, NOV.AX's ROE is -0.78%, compared to SPX.AX's ROE of -1.58%. Regarding short-term risk, NOV.AX is less volatile compared to SPX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check SPX.AX's competition here
NOV.AX vs NET.AX Comparison April 2026
NOV.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NOV.AX stands at 15.5M. In comparison, NET.AX has a market cap of 248.4K. Regarding current trading prices, NOV.AX is priced at A$0.03, while NET.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NOV.AX currently has a P/E ratio of -1.25, whereas NET.AX's P/E ratio is -0.02. In terms of profitability, NOV.AX's ROE is -0.78%, compared to NET.AX's ROE of +0.79%. Regarding short-term risk, NOV.AX is less volatile compared to NET.AX. This indicates potentially lower risk in terms of short-term price fluctuations for NOV.AX.Check NET.AX's competition here